与化疗相比,新的淋巴瘤治疗显示出希望,改善了存活率并减少了副作用。 New lymphoma treatments show promise, improving survival and reducing side effects compared to chemotherapy.

淋巴瘤的新治疗,包括先进的免疫疗法和有针对性的药物,在临床试验中正在显示出有希望的成果,为选择有限的病人带来了新的希望。 New treatments for lymphoma, including advanced immunotherapies and targeted drugs, are showing promising results in clinical trials, offering renewed hope for patients with limited options. 包括Rahul Bhargava博士在内的专家强调,与传统化疗相比,存活率有所提高,副作用减少。 Experts, including Dr. Rahul Bhargava, highlight improved survival rates and fewer side effects compared to traditional chemotherapy. 这些疗法对重发性或复发性病例特别有效,标志着癌症护理方面的重大进步。 These therapies are particularly effective for aggressive or relapsed cases, marking a significant advancement in cancer care.